Cspc Pharmaceutical | 1093 - Current Liabilities


Cspc Pharmaceutical reported CNY10.18B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 160.86M 13.02M Jun/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
Avita Medical AUD 62.68M 77K Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Jiangsu Hengrui CNY 6.9B 2.65B Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Moderna USD 2.53B 139M Jun/2026
Organon & Co USD 2.62B 116M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Sh Fosun Pharma CNY 35.3B 3.29B Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Viatris USD 6.35B 464.5M Jun/2026
Wuxi Apptec CNY 23.85B 4.94B Sep/2026
Xeris Pharmaceuticals USD 189.57M 70.97M Jun/2026
Zz Pientze Pharmaceu CNY 3.02B 742.54M Jun/2026